Visit our Expo - Redox and Inflammation signaling 2012

Thursday January 26th, 2006 (Early morning session)
7h30 – 8h30 : Receptor Signaling : Short communications
7h30 – 7h40 : Jan. S. Jepsen (Danish Cancer Society, Copenhagen, Denmark ) :
Protein Kinase C alpha as a potential target in the treatment of acquired antiestrogen
resistance of human breast cancer.
7h40 – 7h50 : Raymond R. Mattingly (Department of Pharmacology and Karmanos Cancer
Institute, Wayne State University, Detroit, Michigan, U.S.A.)
Increased EGF Receptor expression and activity is induced by deregulated N-Ras and may
provide a therapeutic target in NF1 neurofibrosarcoma
7h50 – 8h00 : Shyamala Maheswaran (Department of Surgical Oncology, Massashusetts
General Hospital, Boston, MA , USA) :
Loss of the Antiproliferative Gene BTG2 in Estrogen Receptor Positive Breast Carcinoma is
Associated with Tumor Grade and Overexpression of Cyclin D1 Protein
8h00 – 8h10 : Xiao C. Li (Division of Hypertension and Vascular Research, Henry Ford
Hospital, Detroit, MI 48202, USA ) :
Cross-talk between angiotensin II and glucagon receptor signaling mediates activation of
mitogen-activated protein kinases ERK 1/2 in rat glomerular mesangial cells.
8h10 – 8h20 : Metoda Lipnik-Stangelj (Department of Pharmacology and Experimental
Toxicology, Faculty of Medicine, University of Ljubljana, Slovenia) :
Multiple role of histamine H1 receptor-PKC-MAPK signalling pathway in histaminestimulated
nerve growth factor secretion from glial cells
8h20 – 8h30 : Ying E. Zhang (Laboratory of Cellular and Molecular Biology, Center for
Cancer Research, National Cancer Institute, National Institutes of Health,
Bethesda, Maryland, USA) :
Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting
MEKK2-JNK pathway
Thursday January 26th, 2006 (Morning session)
8h30 - 10h30: Receptor signaling
8h30 – 9h00 : Walter Birchmeier (Max-Delbruck-Center for Molecular Medicine, Berlin,
Germany):
The role of Met-Gab1 Signalling in vivo.
9h00 – 9h30 : Ulf R. Rapp (Institut fuer Medizinische Strahlenkunde und Zellforschung
(MSZ), Wuerzburg, Germany):
Role of Prohibtin and E-cadherin in Raf mediated oncogenesis
9h30 – 10h00 : Johannes L. Bos (Dept of Physiological Chemistry, Utrecht, The
Netherlands):
Epac and Rap1 in the control of cell adhesion
10h00 – 10h10 : Jean-Paul Borg (Molecular Pharmacology, Marseille Cancer Institute,
UMR599 Inserm-Institut Paoli-Calmettes, Marseille, France) :
- 15 -